Electronic Patient Records
Hiya
I work in a clinical research within an NHS healthcare setting . We are changing our electronic patient record system and consideration is being given to how the source data which is contained within it can meet all the required standards.
I want to ensure that we are future proofing this as much as possible and also to ensure we have considered all the applicable standards.
Obviously GCP standards apply and some sponsors have expectations for us to meet the federal regs 21 CFR Part 11.
Is anyone able to point out whether there are any other specific trial related standards that are out there that we ought to consider?
Many thanks
paper and electronic medical notes source data discrepancy
Hi,
I am pretty new to monitoring and so have a lot of questions about almost every process.
Our Trust has shifted now to electronic medical notes; however some patients in a trial would have some visits recorded on paper records, and some on both paper and electronic. Would both paper and electronic be considered source then? I came across a discrepancy today where data in the paper differed from that in the electronic. The paper record was entered by a nurse and signed off by PI, and the electronic notes was typed in by the PI himself. How should the team solve this?
Many thanks in advance.
[QUOTE=a123456;1250]Here are some useful references:_
European Medicines Agency (EMA) GCP Inspectors Working Group. Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials,(Final), 09 June 2010.
Clinical Data Interchange Standards Consortium (CDISC) e-SDI Group. CDISC Standards and electronic
Source Data within Clinical Trials, 20 November 2006.
Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Guidance for Industry – Computerized Systems Used In Clinical Investigations, May 2007.
Food and Drug Administration. 21 Code of Federal Regulations Part 11 – Electronic Records, Electronic Signatures.
Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics
Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Guidance for Industry – Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims, December 2009.
Practical Considerations for Clinical Trial Sites using Electronic Health Records (EHRs) in support of Clinical Research Addressing Regulatory Considerations (Release 1.0), 2 April 2009. Electronic Health Records for Clinical Research (EHRCR) Working Group
FDA Guidance for Industry Electronic Source Documentation in Clinical Investigations draft guidance Dec 2010[/QUOTE]